Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae



Status:Not yet recruiting
Healthy:No
Age Range:18 - Any
Updated:3/2/2019
Start Date:February 25, 2019
End Date:May 11, 2020
Contact:Aamir Siddiqui, M.D.
Email:ASIDDIQ1@hfhs.org
Phone:313-916-2683

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae: FADeS Trial

This study evaluates the efficacy of treatment of striae distensae using the combined
modality of fractional laser and poly-L lactic acid (Sculptra).

Striae Distensae (SD) is a form of scarring that can oftentimes be quite disfiguring and
emotionally distressing to individuals.

Fractional laser therapy has been used by doctors to treat stretch marks by stimulating
collagen growth.

Poly-L lactic acid also promotes collagen growth in the areas injected.

The combination of laser and poly-L lactic acid might provide the optimal treatment modality
for SD by decreasing the appearance of atrophic scars.

Inclusion Criteria:

- Subject has bilateral striae alba

- Subject has stable body weight for at least 6 months with Fitzpatrick skin type 1-4

Exclusion Criteria:

- Subject has striae rubra

- Pregnant

- History of adverse effects to phototherapy

- Subject has single sided lesions

- Subject has immunosuppression

- Subject has radiation therapy to the study area

- Subject has topical or oral steroid use or chemotherapy within the last 6 months

- History of keloids or hypertrophic scar
We found this trial at
1
site
Henry Ford Health System
Detroit, Michigan 48202
Principal Investigator: Aamir Siddiqui, M.D.
Phone: 313-916-2683
?
mi
from
Detroit, MI
Click here to add this to my saved trials